439 related articles for article (PubMed ID: 19797525)
1. Human-induced pluripotent stem cells from blood cells of healthy donors and patients with acquired blood disorders.
Ye Z; Zhan H; Mali P; Dowey S; Williams DM; Jang YY; Dang CV; Spivak JL; Moliterno AR; Cheng L
Blood; 2009 Dec; 114(27):5473-80. PubMed ID: 19797525
[TBL] [Abstract][Full Text] [Related]
2. Differential sensitivity to JAK inhibitory drugs by isogenic human erythroblasts and hematopoietic progenitors generated from patient-specific induced pluripotent stem cells.
Ye Z; Liu CF; Lanikova L; Dowey SN; He C; Huang X; Brodsky RA; Spivak JL; Prchal JT; Cheng L
Stem Cells; 2014 Jan; 32(1):269-78. PubMed ID: 24105986
[TBL] [Abstract][Full Text] [Related]
3. Erythroid differentiation of human induced pluripotent stem cells is independent of donor cell type of origin.
Dorn I; Klich K; Arauzo-Bravo MJ; Radstaak M; Santourlidis S; Ghanjati F; Radke TF; Psathaki OE; Hargus G; Kramer J; Einhaus M; Kim JB; Kögler G; Wernet P; Schöler HR; Schlenke P; Zaehres H
Haematologica; 2015 Jan; 100(1):32-41. PubMed ID: 25326431
[TBL] [Abstract][Full Text] [Related]
4. Efficient Generation of β-Globin-Expressing Erythroid Cells Using Stromal Cell-Derived Induced Pluripotent Stem Cells from Patients with Sickle Cell Disease.
Uchida N; Haro-Mora JJ; Fujita A; Lee DY; Winkler T; Hsieh MM; Tisdale JF
Stem Cells; 2017 Mar; 35(3):586-596. PubMed ID: 27739611
[TBL] [Abstract][Full Text] [Related]
5. GATA2 deficiency and human hematopoietic development modeled using induced pluripotent stem cells.
Jung M; Cordes S; Zou J; Yu SJ; Guitart X; Hong SG; Dang V; Kang E; Donaires FS; Hassan SA; Albitar M; Hsu AP; Holland SM; Hickstein DD; Townsley D; Dunbar CE; Winkler T
Blood Adv; 2018 Dec; 2(23):3553-3565. PubMed ID: 30538114
[TBL] [Abstract][Full Text] [Related]
6. Screening of drugs to treat 8p11 myeloproliferative syndrome using patient-derived induced pluripotent stem cells with fusion gene CEP110-FGFR1.
Yamamoto S; Otsu M; Matsuzaka E; Konishi C; Takagi H; Hanada S; Mochizuki S; Nakauchi H; Imai K; Tsuji K; Ebihara Y
PLoS One; 2015; 10(3):e0120841. PubMed ID: 25803811
[TBL] [Abstract][Full Text] [Related]
7. A novel serum-free monolayer culture for orderly hematopoietic differentiation of human pluripotent cells via mesodermal progenitors.
Niwa A; Heike T; Umeda K; Oshima K; Kato I; Sakai H; Suemori H; Nakahata T; Saito MK
PLoS One; 2011; 6(7):e22261. PubMed ID: 21818303
[TBL] [Abstract][Full Text] [Related]
8. Effective generation of iPS cells from CD34+ cord blood cells by inhibition of p53.
Takenaka C; Nishishita N; Takada N; Jakt LM; Kawamata S
Exp Hematol; 2010 Feb; 38(2):154-62. PubMed ID: 19922768
[TBL] [Abstract][Full Text] [Related]
9. Efficient hematopoietic redifferentiation of induced pluripotent stem cells derived from primitive murine bone marrow cells.
Pfaff N; Lachmann N; Kohlscheen S; Sgodda M; Araúzo-Bravo MJ; Greber B; Kues W; Glage S; Baum C; Niemann H; Schambach A; Cantz T; Moritz T
Stem Cells Dev; 2012 Mar; 21(5):689-701. PubMed ID: 21732815
[TBL] [Abstract][Full Text] [Related]
10. Generation of CD34 Fluorescent Reporter Human Induced Pluripotent Stem Cells for Monitoring Hematopoietic Differentiation.
Husa AM; Strobl MR; Strajeriu A; Wieser M; Strehl S; Fortschegger K
Stem Cells Dev; 2018 Oct; 27(19):1376-1384. PubMed ID: 30009677
[TBL] [Abstract][Full Text] [Related]
11. Efficient and simultaneous generation of hematopoietic and vascular progenitors from human induced pluripotent stem cells.
Park TS; Zimmerlin L; Zambidis ET
Cytometry A; 2013 Jan; 83(1):114-26. PubMed ID: 22736485
[TBL] [Abstract][Full Text] [Related]
12. Generation of induced pluripotent stem cells by efficient reprogramming of adult bone marrow cells.
Kunisato A; Wakatsuki M; Kodama Y; Shinba H; Ishida I; Nagao K
Stem Cells Dev; 2010 Feb; 19(2):229-38. PubMed ID: 19558219
[TBL] [Abstract][Full Text] [Related]
13. Heterozygous and homozygous JAK2(V617F) states modeled by induced pluripotent stem cells from myeloproliferative neoplasm patients.
Saliba J; Hamidi S; Lenglet G; Langlois T; Yin J; Cabagnols X; Secardin L; Legrand C; Galy A; Opolon P; Benyahia B; Solary E; Bernard OA; Chen L; Debili N; Raslova H; Norol F; Vainchenker W; Plo I; Di Stefano A
PLoS One; 2013; 8(9):e74257. PubMed ID: 24066127
[TBL] [Abstract][Full Text] [Related]
14. β-Globin-Expressing Definitive Erythroid Progenitor Cells Generated from Embryonic and Induced Pluripotent Stem Cell-Derived Sacs.
Fujita A; Uchida N; Haro-Mora JJ; Winkler T; Tisdale J
Stem Cells; 2016 Jun; 34(6):1541-52. PubMed ID: 26866725
[TBL] [Abstract][Full Text] [Related]
15. Blood cell-derived induced pluripotent stem cells free of reprogramming factors generated by Sendai viral vectors.
Ye L; Muench MO; Fusaki N; Beyer AI; Wang J; Qi Z; Yu J; Kan YW
Stem Cells Transl Med; 2013 Aug; 2(8):558-66. PubMed ID: 23847002
[TBL] [Abstract][Full Text] [Related]
16. CRISPR/Cas9 mediated CXCL4 knockout in human iPS cells of polycythemia vera patient with JAK2 V617F mutation.
Boehnke J; Atakhanov S; Toledo MAS; Schüler HM; Sontag S; Chatain N; Koschmieder S; Brümmendorf TH; Kramann R; Zenke M
Stem Cell Res; 2021 Aug; 55():102490. PubMed ID: 34391098
[TBL] [Abstract][Full Text] [Related]
17. Induced pluripotent stem cells expressing elevated levels of sox-2, oct-4, and klf-4 are severely reduced in their differentiation from mesodermal to hematopoietic progenitor cells.
Seiler K; Soroush Noghabi M; Karjalainen K; Hummel M; Melchers F; Tsuneto M
Stem Cells Dev; 2011 Jul; 20(7):1131-42. PubMed ID: 21348597
[TBL] [Abstract][Full Text] [Related]
18. Establishment of isogenic induced pluripotent stem cells with or without pathogenic mutation for understanding the pathogenesis of myeloproliferative neoplasms.
Liu C; Imai M; Edahiro Y; Mano S; Takei H; Nudejima M; Kurose A; Morishita S; Ando M; Tsuneda S; Araki M; Komatsu N
Exp Hematol; 2023 Feb; 118():12-20. PubMed ID: 36511286
[TBL] [Abstract][Full Text] [Related]
19. Identification and isolation from either adult human bone marrow or G-CSF-mobilized peripheral blood of CD34(+)/CD133(+)/CXCR4(+)/ Lin(-)CD45(-) cells, featuring morphological, molecular, and phenotypic characteristics of very small embryonic-like (VSEL) stem cells.
Sovalat H; Scrofani M; Eidenschenk A; Pasquet S; Rimelen V; Hénon P
Exp Hematol; 2011 Apr; 39(4):495-505. PubMed ID: 21238532
[TBL] [Abstract][Full Text] [Related]
20. Potential of human induced pluripotent stem cells derived from blood and other postnatal cell types.
Ye Z; Cheng L
Regen Med; 2010 Jul; 5(4):521-30. PubMed ID: 20632856
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
